Bupivacaine Liposome Injectable Suspension Market - Global Outlook and Forecast 2022-2028

March 2022 | 76 pages | ID: B7AA0E8DE33FEN
Market Monitor Global

Abstracts

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.

This report contains market size and forecasts of Bupivacaine Liposome Injectable Suspension in global, including the following market information:

Global Bupivacaine Liposome Injectable Suspension Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bupivacaine Liposome Injectable Suspension Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bupivacaine Liposome Injectable Suspension companies in 2021 (%)

The global Bupivacaine Liposome Injectable Suspension market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bupivacaine Liposome Injectable Suspension include Pacira Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bupivacaine Liposome Injectable Suspension manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bupivacaine Liposome Injectable Suspension Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Liposome Injectable Suspension Market Segment Percentages, by Type, 2021 (%)

• 20ml
• 10ml

Global Bupivacaine Liposome Injectable Suspension Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Liposome Injectable Suspension Market Segment Percentages, by Application, 2021 (%)

• Veterinary
• Human

Global Bupivacaine Liposome Injectable Suspension Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bupivacaine Liposome Injectable Suspension Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bupivacaine Liposome Injectable Suspension revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bupivacaine Liposome Injectable Suspension revenues share in global market, 2021 (%)

Key companies Bupivacaine Liposome Injectable Suspension sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Bupivacaine Liposome Injectable Suspension sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pacira Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bupivacaine Liposome Injectable Suspension Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bupivacaine Liposome Injectable Suspension Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION OVERALL MARKET SIZE

2.1 Global Bupivacaine Liposome Injectable Suspension Market Size: 2021 VS 2028
2.2 Global Bupivacaine Liposome Injectable Suspension Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bupivacaine Liposome Injectable Suspension Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Bupivacaine Liposome Injectable Suspension Players in Global Market
3.2 Top Global Bupivacaine Liposome Injectable Suspension Companies Ranked by Revenue
3.3 Global Bupivacaine Liposome Injectable Suspension Revenue by Companies
3.4 Global Bupivacaine Liposome Injectable Suspension Sales by Companies
3.5 Global Bupivacaine Liposome Injectable Suspension Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bupivacaine Liposome Injectable Suspension Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bupivacaine Liposome Injectable Suspension Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bupivacaine Liposome Injectable Suspension Players in Global Market
  3.8.1 List of Global Tier 1 Bupivacaine Liposome Injectable Suspension Companies
  3.8.2 List of Global Tier 2 and Tier 3 Bupivacaine Liposome Injectable Suspension Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bupivacaine Liposome Injectable Suspension Market Size Markets, 2021 & 2028
  4.1.2 20ml
  4.1.3 10ml
4.2 By Type - Global Bupivacaine Liposome Injectable Suspension Revenue & Forecasts
  4.2.1 By Type - Global Bupivacaine Liposome Injectable Suspension Revenue, 2017-2022
  4.2.2 By Type - Global Bupivacaine Liposome Injectable Suspension Revenue, 2023-2028
  4.2.3 By Type - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
4.3 By Type - Global Bupivacaine Liposome Injectable Suspension Sales & Forecasts
  4.3.1 By Type - Global Bupivacaine Liposome Injectable Suspension Sales, 2017-2022
  4.3.2 By Type - Global Bupivacaine Liposome Injectable Suspension Sales, 2023-2028
  4.3.3 By Type - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
4.4 By Type - Global Bupivacaine Liposome Injectable Suspension Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bupivacaine Liposome Injectable Suspension Market Size, 2021 & 2028
  5.1.2 Veterinary
  5.1.3 Human
5.2 By Application - Global Bupivacaine Liposome Injectable Suspension Revenue & Forecasts
  5.2.1 By Application - Global Bupivacaine Liposome Injectable Suspension Revenue, 2017-2022
  5.2.2 By Application - Global Bupivacaine Liposome Injectable Suspension Revenue, 2023-2028
  5.2.3 By Application - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
5.3 By Application - Global Bupivacaine Liposome Injectable Suspension Sales & Forecasts
  5.3.1 By Application - Global Bupivacaine Liposome Injectable Suspension Sales, 2017-2022
  5.3.2 By Application - Global Bupivacaine Liposome Injectable Suspension Sales, 2023-2028
  5.3.3 By Application - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
5.4 By Application - Global Bupivacaine Liposome Injectable Suspension Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bupivacaine Liposome Injectable Suspension Market Size, 2021 & 2028
6.2 By Region - Global Bupivacaine Liposome Injectable Suspension Revenue & Forecasts
  6.2.1 By Region - Global Bupivacaine Liposome Injectable Suspension Revenue, 2017-2022
  6.2.2 By Region - Global Bupivacaine Liposome Injectable Suspension Revenue, 2023-2028
  6.2.3 By Region - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
6.3 By Region - Global Bupivacaine Liposome Injectable Suspension Sales & Forecasts
  6.3.1 By Region - Global Bupivacaine Liposome Injectable Suspension Sales, 2017-2022
  6.3.2 By Region - Global Bupivacaine Liposome Injectable Suspension Sales, 2023-2028
  6.3.3 By Region - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028
  6.4.2 By Country - North America Bupivacaine Liposome Injectable Suspension Sales, 2017-2028
  6.4.3 US Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.4.4 Canada Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.4.5 Mexico Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028
  6.5.2 By Country - Europe Bupivacaine Liposome Injectable Suspension Sales, 2017-2028
  6.5.3 Germany Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.4 France Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.5 U.K. Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.6 Italy Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.7 Russia Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.8 Nordic Countries Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.5.9 Benelux Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028
  6.6.2 By Region - Asia Bupivacaine Liposome Injectable Suspension Sales, 2017-2028
  6.6.3 China Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.6.4 Japan Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.6.5 South Korea Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.6.6 Southeast Asia Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.6.7 India Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028
  6.7.2 By Country - South America Bupivacaine Liposome Injectable Suspension Sales, 2017-2028
  6.7.3 Brazil Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.7.4 Argentina Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Sales, 2017-2028
  6.8.3 Turkey Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.8.4 Israel Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.8.5 Saudi Arabia Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028
  6.8.6 UAE Bupivacaine Liposome Injectable Suspension Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pacira Pharmaceuticals
  7.1.1 Pacira Pharmaceuticals Corporate Summary
  7.1.2 Pacira Pharmaceuticals Business Overview
  7.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Major Product Offerings
  7.1.4 Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales and Revenue in Global (2017-2022)
  7.1.5 Pacira Pharmaceuticals Key News

8 GLOBAL BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION PRODUCTION CAPACITY, ANALYSIS

8.1 Global Bupivacaine Liposome Injectable Suspension Production Capacity, 2017-2028
8.2 Bupivacaine Liposome Injectable Suspension Production Capacity of Key Manufacturers in Global Market
8.3 Global Bupivacaine Liposome Injectable Suspension Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BUPIVACAINE LIPOSOME INJECTABLE SUSPENSION SUPPLY CHAIN ANALYSIS

10.1 Bupivacaine Liposome Injectable Suspension Industry Value Chain
10.2 Bupivacaine Liposome Injectable Suspension Upstream Market
10.3 Bupivacaine Liposome Injectable Suspension Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Bupivacaine Liposome Injectable Suspension Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Bupivacaine Liposome Injectable Suspension in Global Market
Table 2. Top Bupivacaine Liposome Injectable Suspension Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bupivacaine Liposome Injectable Suspension Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bupivacaine Liposome Injectable Suspension Revenue Share by Companies, 2017-2022
Table 5. Global Bupivacaine Liposome Injectable Suspension Sales by Companies, (K Units), 2017-2022
Table 6. Global Bupivacaine Liposome Injectable Suspension Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bupivacaine Liposome Injectable Suspension Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Bupivacaine Liposome Injectable Suspension Product Type
Table 9. List of Global Tier 1 Bupivacaine Liposome Injectable Suspension Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bupivacaine Liposome Injectable Suspension Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2017-2022
Table 15. By Type - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2023-2028
Table 16. By Application – Global Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2017-2022
Table 20. By Application - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2023-2028
Table 21. By Region – Global Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bupivacaine Liposome Injectable Suspension Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2017-2022
Table 25. By Region - Global Bupivacaine Liposome Injectable Suspension Sales (K Units), 2023-2028
Table 26. By Country - North America Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2017-2022
Table 29. By Country - North America Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2023-2028
Table 38. By Country - South America Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2017-2022
Table 41. By Country - South America Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Sales, (K Units), 2023-2028
Table 46. Pacira Pharmaceuticals Corporate Summary
Table 47. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Product Offerings
Table 48. Pacira Pharmaceuticals Bupivacaine Liposome Injectable Suspension Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bupivacaine Liposome Injectable Suspension Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Bupivacaine Liposome Injectable Suspension Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Bupivacaine Liposome Injectable Suspension Production by Region, 2017-2022 (K Units)
Table 52. Global Bupivacaine Liposome Injectable Suspension Production by Region, 2023-2028 (K Units)
Table 53. Bupivacaine Liposome Injectable Suspension Market Opportunities & Trends in Global Market
Table 54. Bupivacaine Liposome Injectable Suspension Market Drivers in Global Market
Table 55. Bupivacaine Liposome Injectable Suspension Market Restraints in Global Market
Table 56. Bupivacaine Liposome Injectable Suspension Raw Materials
Table 57. Bupivacaine Liposome Injectable Suspension Raw Materials Suppliers in Global Market
Table 58. Typical Bupivacaine Liposome Injectable Suspension Downstream
Table 59. Bupivacaine Liposome Injectable Suspension Downstream Clients in Global Market
Table 60. Bupivacaine Liposome Injectable Suspension Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Bupivacaine Liposome Injectable Suspension Segment by Type
Figure 2. Bupivacaine Liposome Injectable Suspension Segment by Application
Figure 3. Global Bupivacaine Liposome Injectable Suspension Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bupivacaine Liposome Injectable Suspension Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bupivacaine Liposome Injectable Suspension Revenue, 2017-2028 (US$, Mn)
Figure 7. Bupivacaine Liposome Injectable Suspension Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bupivacaine Liposome Injectable Suspension Revenue in 2021
Figure 9. By Type - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 10. By Type - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bupivacaine Liposome Injectable Suspension Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 13. By Application - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bupivacaine Liposome Injectable Suspension Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 16. By Region - Global Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 19. US Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 24. Germany Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 25. France Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 33. China Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 37. India Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 40. Brazil Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bupivacaine Liposome Injectable Suspension Sales Market Share, 2017-2028
Figure 44. Turkey Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bupivacaine Liposome Injectable Suspension Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bupivacaine Liposome Injectable Suspension Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bupivacaine Liposome Injectable Suspension by Region, 2021 VS 2028
Figure 50. Bupivacaine Liposome Injectable Suspension Industry Value Chain
Figure 51. Marketing Channels